Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Récepteur FGFR3")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 127

  • Page / 6
Export

Selection :

  • and

Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumorsCHENGLIU JIN; FEN WANG; XIAOCHONG WU et al.Cancer research (Baltimore). 2004, Vol 64, Num 13, pp 4555-4562, issn 0008-5472, 8 p.Article

An activating Fgfr3 mutation affects trabecular bone formation via a paracrine mechanism during growthMUGNIERY, Emilie; DACQUIN, Romain; MARTY, Caroline et al.Human molecular genetics (Print). 2012, Vol 21, Num 11, pp 2503-2513, issn 0964-6906, 11 p.Article

Disruption of a Sox9―β-catenin circuit by mutant Fgfr3 in thanatophoric dysplasia type IISHUNG, Chia-Yi; OTA, Sara; ZHOU, Zi-Qiang et al.Human molecular genetics (Print). 2012, Vol 21, Num 21, pp 4628-4644, issn 0964-6906, 17 p.Article

Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratosesHAFNER, Christian; HARTMANN, Arndt; REAL, Francisco X et al.Journal of investigative dermatology. 2007, Vol 127, Num 8, pp 1883-1885, issn 0022-202X, 3 p.Article

FGFR3 is a target of the homeobox transcription factor SHOX in limb developmentDECKER, Eva; DURAND, Claudia; BENDER, Sebastian et al.Human molecular genetics (Print). 2011, Vol 20, Num 8, pp 1524-1535, issn 0964-6906, 12 p.Article

Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myelomaPATERSON, Joshua L; ZHIHUA LI; WEN, Xiao-Yan et al.British journal of haematology. 2004, Vol 124, Num 5, pp 595-603, issn 0007-1048, 9 p.Article

FGFR3 and FGFR4 Do not Mediate Renal Effects of FGF23SHIGUANG LIU; VIERTHALER, Luke; WEN TANG et al.Journal of the American Society of Nephrology. 2008, Vol 19, Num 12, pp 2342-2350, issn 1046-6673, 9 p.Article

Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growthGOMEZ-ROMAN, J. Javier; SAENZ, Pilar; ESPARZA, Clara et al.Clinical cancer research. 2005, Vol 11, Num 2, pp 459-465, issn 1078-0432, 7 p., 1Article

Nordihydroguaiaretic Acid Inhibits an Activated Fibroblast Growth Factor Receptor 3 Mutant and Blocks Downstream Signaling in Multiple Myeloma CellsMEYER, April N; MCANDREW, Christopher W; DONOGHUE, Daniel J et al.Cancer research (Chicago, Ill.). 2008, Vol 68, Num 18, pp 7362-7370, issn 0008-5472, 9 p.Article

A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse modelJONQUOY, Aurélie; MUGNIERY, Emilie; MUNNICH, Arnold et al.Human molecular genetics (Print). 2012, Vol 21, Num 4, pp 841-851, issn 0964-6906, 11 p.Article

Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cellsCHADALAPAKA, Gayathri; JUTOORU, Indira; SAFE, Stephen et al.Carcinogenesis (New York. Print). 2012, Vol 33, Num 4, pp 886-894, issn 0143-3334, 9 p.Article

A novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasiaMIN JIN; YING YU; XIAOLAN DU et al.Human molecular genetics (Print). 2012, Vol 21, Num 26, pp 5443-5455, issn 0964-6906, 13 p.Article

Constitutively activated FGFR3 mutants signal through PLCγ-dependent and -independent pathways for hematopoietic transformationJING CHEN; WILLIAMS, Ifor R; LEE, Benjamin H et al.Blood. 2005, Vol 106, Num 1, pp 328-337, issn 0006-4971, 10 p.Article

FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladderBAKKAR, Ashraf A; WALLERAND, Herve; THIERY, Jean-Paul et al.Cancer research (Baltimore). 2003, Vol 63, Num 23, pp 8108-8112, issn 0008-5472, 5 p.Article

High frequency of FGFR3 mutations in adenoid seborrheic keratosesHAFNER, Christian; VAN OERS, Johanna M. M; HARTMANN, Arndt et al.Journal of investigative dermatology. 2006, Vol 126, Num 11, pp 2404-2407, issn 0022-202X, 4 p.Article

Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074GRAND, E. K; CHASE, A. J; HEATH, C et al.Leukemia. 2004, Vol 18, Num 5, pp 962-966, issn 0887-6924, 5 p.Article

CHIR-258 is efficacious in a newly developed fibroblast growth factor receptor 3- expressing orthotopic multiple myeloma model in miceXIAOHUA XIN; ABRAMS, Tinya J; TRUDEL, Suzanne et al.Clinical cancer research. 2006, Vol 12, Num 16, pp 4908-4915, issn 1078-0432, 8 p.Article

Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16.3;q32) in multiple myelomaSTEWART, James Peter; THOMPSON, Alexander; SANTRA, Madhumita et al.British journal of haematology. 2004, Vol 126, Num 1, pp 72-76, issn 0007-1048, 5 p.Article

Identification of ID-1 as a potential target gene of MMSET in multiple myelomaHUDLEBUSCH, Heidi Rye; THEILGAARD-MÖNCH, Kim; LODAHL, Marianne et al.British journal of haematology. 2005, Vol 130, Num 5, pp 700-708, issn 0007-1048, 9 p.Article

Role of activating Fibroblast growth factor receptor 3 mutations in the development of bladder tumorsZIEGER, Karsten; DYRSKJØT, Lars; WIUF, Carsten et al.Clinical cancer research. 2005, Vol 11, Num 21, pp 7709-7719, issn 1078-0432, 11 p.Article

FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinomaVAN RHIJN, Bas W. G; VAN DER KWAST, Theo H; VIS, André N et al.Cancer research (Baltimore). 2004, Vol 64, Num 6, pp 1911-1914, issn 0008-5472, 4 p.Article

Colorectal Cancer Cells Activate Adjacent Fibroblasts Resulting in FGF1/FGFR3 Signaling and Increased InvasionHENRIKSSON, Maria L; EDIN, Sofia; DAHLIN, Anna M et al.The American journal of pathology. 2011, Vol 178, Num 3, pp 1387-1394, issn 0002-9440, 8 p.Article

Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivoLAMONT, F. R; TOMLINSON, D. C; COOPER, P. A et al.British journal of cancer. 2011, Vol 104, Num 1, pp 75-82, issn 0007-0920, 8 p.Article

Bortezomib Therapeutic Effect Is Associated with Expression and Mutation of FGFR3 in Human Lymphoma CellsWEIYAN ZHENG; MIN GUAN; LIJUN ZHU et al.Anticancer research. 2010, Vol 30, Num 6, pp 1921-1930, issn 0250-7005, 10 p.Article

Bortezomib Therapeutic Effect is Associated with Expression of FGFR3 in Multiple Myeloma CellsMIN GUAN; LIJUN ZHU; SOMLO, George et al.Anticancer research. 2009, Vol 29, Num 1, pp 1-9, issn 0250-7005, 9 p.Article

  • Page / 6